Pharma-Bio Serv
Stock Forecast, Prediction & Price Target
Pharma-Bio Serv Financial Estimates
Pharma-Bio Serv Revenue Estimates
Pharma-Bio Serv EBITDA Estimates
Pharma-Bio Serv Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 10/31/2021 | 10/31/2022 | 10/31/2023 | 10/31/2025 | |||
Revenue
% change YoY
| $20.11M N/A | $19.39M -3.56% | $16.97M -12.48% | Avg: $20.2M Low: $20.2M High: $20.2M avg. 18.98% | |||
Net Income
% change YoY
| $-2.08M N/A | $1.00M 148.18% | $1.31M 30.14% | Avg: $2.52M Low: $2.52M High: $2.52M avg. 93.08% | |||
EBITDA
% change YoY
| $-3.78M N/A | $1.22M 132.42% | $1.31M 6.98% | Avg: $613.14K Low: $613.14K High: $613.14K avg. -53.25% | |||
EPS
% change YoY
| -$0.09 N/A | $0.04 148.29% | $0.06 30.13% | Avg: $0.11 Low: $0.11 High: $0.11 avg. 92.98% | |||
Operating Expenses
% change YoY
| $9.21M N/A | $3.70M -59.77% | $3.94M 6.54% | Avg: $5.32M Low: $5.32M High: $5.32M avg. 34.76% | |||
FAQ
What is Pharma-Bio Serv stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 93.08% in 2025-2025.
We have gathered data from 1 analysts. Their low estimate is 2.52M, average is 2.52M and high is 2.52M.
What is Pharma-Bio Serv stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 18.98% in 2025-2025.
We have gathered data from 1 analysts. Their low revenue estimate is $20.2M, average is $20.2M and high is $20.2M.
What is Pharma-Bio Serv stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 92.98% in 2025-2025.
We have gathered data from 1 analysts. Their low earnings per share estimate is $0.11, average is $0.11 and high is $0.11.